Aligned Genetics Inc. (238120)

Overview

Aligned Genetics, Inc., originating as Logos Biosystems, Inc., underwent a significant rebranding in September 2020 to better reflect its evolving focus within the biotech industry. Since its establishment in 2008, this South Korean-based company has carved out a niche in the global market, by pioneering advanced imaging solutions tailored for research institutions. With a broad international footprint, Aligned Genetics, Inc. prides itself on forging partnerships through distributors, ensuring their cutting-edge technologies are accessible to a wide array of researchers and institutions seeking to push the boundaries of cellular and tissue imaging.

Products and Services

Aligned Genetics, Inc. specializes in a range of innovative imaging solutions, each designed to meet the unique needs of researchers in the field of biotechnology:

• Digital Cell Imaging: Offering a suite of sophisticated tools and devices that enable researchers to capture and analyze cellular images with unprecedented clarity and detail. These systems are built to facilitate a deeper understanding of cell behavior and function, providing invaluable insights into biological processes.
• Tissue Clearing and 3D Imaging: Revolutionizing the study of complex tissue structures through technology that renders tissues transparent, thus allowing for intricate 3D imaging. This breakthrough approach enables scientists to visualize and analyze the inner workings of tissues in a holistic manner, opening up new avenues for research in developmental biology, neurology, and various medical fields.